Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antirheumatic medication in pregnancy.

C J Needs, P M Brooks

    British Journal of Rheumatology
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Before prescribing medications for women of childbearing age, consider fetal effects and teratogenesis. Nonsteroidal anti-inflammatory drugs (NSAIDs) can prolong labor and pose risks, necessitating careful drug selection and dosage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Australia needs an Ombudsman or Office for Research Integrity.

    Internal medicine journal·2016
    Same author

    The management of rheumatoid arthritis.

    The Australian journal of physiotherapy·2014
    Same author

    The patient is the teacher: ambulatory patient-centred student-based interprofessional education where the patient is the teacher who improves patient care outcomes.

    Internal medicine journal·2013
    Same author

    The clinical significance of indomethacin-probenecid interaction.

    British journal of clinical pharmacology·2012
    Same author

    The effect of frusemide on indomethacin plasma levels.

    British journal of clinical pharmacology·2012
    Same author

    Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they?

    Inflammopharmacology·2008
    Same journal

    Sensorineural hearing loss, iritis and ankylosing spondylitis.

    British journal of rheumatology·1999
    Same journal

    Outcome in systemic vasculitis.

    British journal of rheumatology·1999
    Same journal

    Infection with an unenveloped DNA virus (TTV) associated with non-A to G hepatitis in patients with rheumatoid arthritis.

    British journal of rheumatology·1999
    Same journal

    Aortitis in relapsing polychondritis.

    British journal of rheumatology·1999
    Same journal

    Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis.

    British journal of rheumatology·1999
    Same journal

    Haemophagocytic syndrome in a patient with dermatomyositis.

    British journal of rheumatology·1999
    See all related articles

    Area of Science:

    • Pharmacology
    • Obstetrics
    • Teratology

    Background:

    • Drug prescribing for women of childbearing age requires careful consideration of fetal physiology and potential teratogenesis.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) can impact pregnancy outcomes due to prostaglandin synthesis inhibition.

    Purpose of the Study:

    • To review the effects of various drugs on fetal development and pregnancy.
    • To provide guidance on the safe use of medications during pregnancy, focusing on NSAIDs and other relevant drug classes.

    Main Methods:

    • Literature review of drug effects on fetal physiology and teratogenesis.
    • Analysis of risks associated with specific drug classes, including NSAIDs, gold salts, corticosteroids, D-penicillamine, and 4-aminoquinoline compounds.

    Related Experiment Videos

    Main Results:

    • NSAIDs may prolong gestation and labor; aspirin increases hemorrhage risk and can cause neonatal pulmonary hypertension.
    • Indomethacin presents teratogenic risks and potential for neonatal pulmonary hypertension.
    • Short-half-life NSAIDs (ibuprofen, flurbiprofen, ketoprofen) at maximal dosage intervals are preferred.
    • Gold salts and corticosteroids have low teratogenicity evidence but require cautious dosing.
    • D-penicillamine carries teratogenic risks and necessitates withdrawal or dose reduction during pregnancy.
    • 4-Aminoquinoline compounds are contraindicated in pregnancy.

    Conclusions:

    • Careful drug selection and dosage adjustments are crucial for pregnant women, especially concerning NSAIDs.
    • Certain medications like D-penicillamine and 4-aminoquinoline compounds should be avoided or managed cautiously during pregnancy due to teratogenic risks.